Oral administration of medicines is an application of choice. To facilitate the achievement of oral administration of newly synthesised active substances, Lipinski described in the rule of five the physicochemical properties that are statistically significant for orally administered compounds. In this thesis, we have determined some of these properties for the compounds and presented the optimal values that influence the pharmacokinetics of the different active substances.
Solubility influences all pharmacokinetic properties, determines whether an active substance will be absorbed, distributed and how fast it will act, and it also affects its metabolism and elimination from the body. The thermodynamic and kinetic solubility was determined by the flask shake method using a pre-prepared calibration concentration curve. For kinetic solubility the stock solution was added to phosphate buffer 7,4, and for thermodynamic solubility, the compound was mixed directly with phosphate buffer.
The first-pass metabolism of the compounds was determined by the fraction of S9 enzyme. Metabolism influences how long the active substance will be in the body and in which concentration it will arrive at the site of action. The enzyme activity was evaluated by concurrent metabolism of testosterone. Metabolic stability of compounds is an important criterion for development and therefore a method for rapid determination in the first stages of development could be essential for potentially orally useful active substances.
The third property that was studied in the context of the thesis was the lipophilicity of the active substances. Lipophilicity, pKa, molecular weight and some physical properties are the most important influences on the permeability of compounds. The permeability of the compounds was determined by measuring logD7.4, in octanol and buffer phosphate 7,4, using the flask shake method.
The concentrations of the analytes for the determination of the properties, were measured using a UHPLC system coupled to a DAD detector, reversed-phase chromatography and using the Chromeleon computer program.
|